225 related articles for article (PubMed ID: 28392354)
1. Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes.
Shanaki M; Moradi N; Emamgholipour S; Fadaei R; Poustchi H
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S467-S472. PubMed ID: 28392354
[TBL] [Abstract][Full Text] [Related]
2. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
3. The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
Shanaki M; Fadaei R; Moradi N; Emamgholipour S; Poustchi H
PLoS One; 2016; 11(12):e0168082. PubMed ID: 27936230
[TBL] [Abstract][Full Text] [Related]
4. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study.
Emamgholipour S; Moradi N; Beigy M; Shabani P; Fadaei R; Poustchi H; Doosti M
Diabetol Metab Syndr; 2015; 7():108. PubMed ID: 26613006
[TBL] [Abstract][Full Text] [Related]
5. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
6. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
[TBL] [Abstract][Full Text] [Related]
7. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
[TBL] [Abstract][Full Text] [Related]
8. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
9. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease.
Ke F; Xue G; Jiang X; Li F; Lai X; Zhang M; Shen Y; Gao L
Cytokine; 2020 Oct; 134():155184. PubMed ID: 32645536
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
11. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L
Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105
[TBL] [Abstract][Full Text] [Related]
13. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus.
Elizondo-Montemayor L; Gonzalez-Gil AM; Tamez-Rivera O; Toledo-Salinas C; Peschard-Franco M; Rodríguez-Gutiérrez NA; Silva-Platas C; Garcia-Rivas G
Mediators Inflamm; 2019; 2019():6737318. PubMed ID: 31015797
[TBL] [Abstract][Full Text] [Related]
14. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels.
Rana KS; Pararasa C; Afzal I; Nagel DA; Hill EJ; Bailey CJ; Griffiths HR; Kyrou I; Randeva HS; Bellary S; Brown JE
Cardiovasc Diabetol; 2017 Nov; 16(1):147. PubMed ID: 29121940
[TBL] [Abstract][Full Text] [Related]
15. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy DH; Ibrahim AA; Ashmawy IO
Diabetes Metab Syndr; 2018 Sep; 12(5):643-648. PubMed ID: 29673927
[TBL] [Abstract][Full Text] [Related]
16. Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?
Shabani P; Naeimi Khaledi H; Beigy M; Emamgholipour S; Parvaz E; Poustchi H; Doosti M
PLoS One; 2015; 10(3):e0118650. PubMed ID: 25767880
[TBL] [Abstract][Full Text] [Related]
17. Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease.
Barchetta I; Cimini FA; De Gioannis R; Ciccarelli G; Bertoccini L; Lenzi A; Baroni MG; Cavallo MG
Diabetes Metab Res Rev; 2018 Jul; 34(5):e2998. PubMed ID: 29471595
[TBL] [Abstract][Full Text] [Related]
18. Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients.
Kaneda H; Nakajima T; Haruyama A; Shibasaki I; Hasegawa T; Sawaguchi T; Kuwata T; Obi S; Arikawa T; Sakuma M; Amano H; Toyoda S; Fukuda H; Inoue T
PLoS One; 2018; 13(8):e0201499. PubMed ID: 30071056
[TBL] [Abstract][Full Text] [Related]
19. High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis.
Moreno-Perez O; Reyes-Garcia R; Muñoz-Torres M; Merino E; Boix V; Reus S; Giner L; Alfayate R; Garcia-Fontana B; Sanchez-Paya J; Picó A; Portilla J
Clin Endocrinol (Oxf); 2018 Oct; 89(4):414-423. PubMed ID: 29947044
[TBL] [Abstract][Full Text] [Related]
20. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study.
Zhang M; Chen P; Chen S; Sun Q; Zeng QC; Chen JY; Liu YX; Cao XH; Ren M; Wang JK
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1567-72. PubMed ID: 24943964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
